How do organisms, and cells within organisms, respond to their environment? In mammals, information conveyed to sensory organs is transmitted to the central nervous system, where the information is processed and converted into a physiological response. At the cellular level, signalling cascades initiated at the cell surface relay a message via effector proteins, ultimately culminating in the nucleus, where transcription factors are targeted to induce or shut down a particular gene expression signature. This event may be transient in nature, for example when a cell needs to respond acutely to an event and then return to its previous steady state. However, the development, health and/or adaptation of an organism often require that an ephemeral environmental signal can be converted into a long-lived phenotypic change. Epigenetic mechanisms, which allow heritable changes in gene expression without altering the genetic sequence, are one powerful way to turn a transient signalling event into a long-lived change in organism performance or function.
Multiple outcomes of a signalling event are possible. When a change in gene expression is required, DNA sequence-specific transcription factors are spurred into action. They can be regulated by several mechanisms, including: altered complex association with co-activators that stimulate transcription or increase DNA sequence specificity 1 ; shuttling into or out of the nucleus driven by changes in post-translational modifications (PTMs) 2 and thereby changes in protein interactions; and u biquitinmediated proteasomal degradation 3 . This paradigm for regulation and activation of transcription factors by signalling cascades initiated at the cell membrane or in the cytoplasm is well established and demonstrates the importance of crosstalk between different cellular compartments. Transcription factors that bind specific DNA sequences function in concert with chromatin regulators to orchestrate a change in the transcriptional programme. Indeed, chromatin-based mechanisms are vital for transcriptional control and include the modification of histones and DNA by 'writer or eraser' proteins and the interpretation of these modifications by 'reader' proteins.
Numerous chemical modifications, identified through mass spectrometry and candidate site analysis, heavily decorate the histone tails 4 . This constellation of various modifications, which together regulate transcriptional outcomes, are often referred to as the 'histone code' 5 . The abundance of modifications raises the question of whether histone tails act as a site of signal integration 6 , where multiple modifications or 'inputs' can convene over time and result in only a few directed outputs, that is, as a multiple-inputs-single-output system. In addition, how do signalling cascades communicate with writer, eraser and reader proteins? Stimuli-induced epigenetic alterations can persist long after the initiating signal is gone. Indeed, epigenetic changes can remain throughout the lifetime of an organism and even be transmitted to subsequent generations 7 . Given these potentially long-term consequences, it is imperative that histone modificatio ns are tightly regulated, but so far little is known about how this occurs. Exciting new studies have highlighted that this can be mediated both by direct, signallingdependent regulation of chromatin-modifying enzymes and signal-induced nuclear complex assembly. It is also becoming clear that signalling events target proteins with histone tail-like sequences, dubbed 'histone mimic s' . These are scattered throughout chromatin-regulatory proteins, and the PTM of some can promote binding of known reader proteins. One possibility, therefore, is that histone mimics might allow a single signalling event to coordinate changes on chromatin by co-modifying not only histones but also their regulators.
The idea that signalling might have direct effects on chromatin was originally postulated over ten years ago, whereby mechanisms of signal transduction that affect receptor Tyr kinases could also function at chromatin 8 .
In this Review, we focus on the new understanding of the molecular basis of signalling to chromatin. We highlight ways in which signalling pathways, with a focus on kinase cascades, can directly regulate nucleosomes and c hromatin-modifying enzymes, eliciting effects on chromatin modification, chromatin remodelling and the deposition of histone variants. We also discuss the many influences that histone mimics can have on chromatin function and speculate that transduction of cellular signals to histone mimics may be coordinated with signal transduction to nucleosomes. We outline the exciting questions that these studies have raised about the intersection between cell signalling and epigenetic regulation. Readers are referred elsewhere for more detailed discussions of DNA damage signalling involving chromatin 9 , the detailed mechanisms of epigenetic transcriptional control [9] [10] [11] and the effects of non-coding RNAs on epigeneti c regulation and transmission 12 .
Signal integration on histones
Cells must coordinate responses to, and have the ability to remember, many stimuli, including signalling cues from other cells, the extracellular matrix, hormones and active compounds. As they are subject to feedback control, response pathways are usually 'on' or 'off ' in nature. By contrast, transcription can be increased or decreased, providing a composite response to multiple inputs over time. In line with this, signal transmission to chromatin followed by the turning on or off of gene transcription can be compared to a digital-to-analogue converter (DAC) that converts on and off signals into a continuous waveform output that can vary in amplitude over time. We speculate that histone tails may function in this way, acting as a site that stores signals and integrates them to regulate the transcriptional programme (FIG. 1) . Indeed, the pure density and variety of PTMs on histones suggest that they are uniquely placed to act as signal integration devices. Histone modifications function in combination, which adds to the diversity of outputs that they might facilitate. Crosstalk between histone modifications occurs in cis and trans by influencing the binding of reader proteins to adjacent residues 13 , by precluding or recruiting enzymes that modify additional sites 14, 15 or through combined effects on complex docking (termed 'multiple site display') [16] [17] [18] [19] [20] (FIG. 1) . Although the underlying mechanisms are not fully understood, the modification landscape can be fully or partially maintained throughout replication, allowing past signalling events to Figure 1 | The histone tails act as a signal storage and converter device. Signals from multiple inputs occurring over time, which are 'on' or 'off' in nature, can be stored on chromatin through post-translational modifications (PTMs) of histone tails. These inputs may affect the chromatin directly or be transmitted through epigenetic enzymes, including factors that 'write' or 'erase' particular marks on histones and chromatin-remodelling factors. The chromatin landscape is constantly interpreted by 'reader' proteins, which are comprised of various domains. This 'signal interpretation' involves a collage of mechanisms whereby the marks present on histones, either directly or through crosstalk, recruit reader proteins and additional enzymes. The crosstalk between different histone modifications can have several effects including: changing the ability of a reader protein to recognize an adjacent mark; recruiting or precluding enzymes that modify additional sites; or creating a combinatorial display for recognition in multivalent binding events. Together, these outcomes can influence the amplitude of a continuous wave of transcriptional output. Ac, acetylation; Me, methylation; P, phosphorylation.
Nucleosome remodellers
ATP-dependent enzymes that catalyse a shift in the nucleosome position relative to the DNA sequence. The various families of remodellers use slightly different mechanisms to facilitate nucleosome repositioning.
Histone chaperones
Proteins that associate with histones to facilitate a number of functions, including histone transfer, deposition into or eviction from chromatin, histone variant utilization and storage.
influence the current state of transcription 21 . As a result, the transcriptional output of a single gene over a time course, or even throughout the entire lifespan of a cell, follows a continuous wave pattern that can be 'dialled' up or down, but that differs from the inputs received at any specific time point. Circadian gene expression is one example of this, whereby chromatin surrounding the CLOCK gene promoter is methylated, acetylated and then deacetylated to control fluctuations in the amplitude of CLOCK gene expression over a 24-hour period 22 . Thus, histone tail post-translational modification has all the features of a biological DAC 'storage and output' device for epigenetic information. Nevertheless, it is ill defined how long a signal can be stored on chromatin. In addition, it is still largely unknown how the chromatin landscape is preserved during DNA replication and cellular division. Thus, determining the variables that define the longevity of marks on histones is crucial for understanding the storage capacity of these marks.
Mechanisms of signalling to chromatin
Chromatin landscape alteration is emerging as a major consequence of signalling events. A signal can be relayed directly to chromatin-modifying enzymes to add or remove chemical modifications to and from histones and DNA. In addition, activated signalling cascades can communicate with nucleosome remodellers and histone chaperones to alter the chromatin structure. In this section, we review such mechanisms and discuss the future work needed to clarify and build on our knowledge of how signalling to chromatin is mediated.
Direct targeting of nucleosomes by kinase cascades.
At the chromatin level, phosphorylation creates docking sites for phospho-binding proteins and acts to temporarily oppose existing or potential modifications on histone tails, such as methylation. Histone methylation has a longer half-life than acetylation 23 or phosphorylation 24 , implying that signal-induced changes in the methylation landscape on chromatin may facilitate long-lived storage or 'memory' of a cellular experience. Conversely, histone phosphorylation and acetylation seem to be more transient and short-lived signals that trigger an immediate switch in chromatin behaviour.
Kinase cascades can directly alter nucleosomes through phosphorylation of histones (for a review, see REFS 25, 26) . For example, Aurora B phosphorylation at Ser10 of histone H3 (H3S10) at the onset of mitosis is necessary for proper chromosome condensation and segregation 27 . This phosphorylation event perturbs methylation and binding of many chromodomaincontaining proteins to the adjacent Lys9 residue in its di-or trimethylated state (H3K9me2/3). As most H3K9me-binding proteins repress transcription and/or condense the chromatin, phosphorylation of Ser10 during interphase activates transcription. The m itogeninduced increase in Ser10 phosphorylation is transient and gradually decreases within an hour of the stimulus 28, 29 , but it is unknown whether this rapid decline requires active dephosphorylation or histone turnover. This path from stimulus to transcription has been elegantly tracked using the progesterone-responsive MMTV (mouse mammary tumour virus) promoter as a model system. It was shown that within 5 minutes of treatment with the synthetic steroid progestin, H3S10 became phosphorylated in the MMTV promoter region in an MSK1 (mitogen-and stress-activated kinase 1)-dependent fashion. Furthermore, H3S10 phosphorylation and associated histone H3 acetylation blocked binding of the chromo-domain protein HP1γ (heterochromatin protein 1γ) and promoted ATP-dependent chromatin remodelling to fully activate target gene transcription 30 . H3S10 phosphorylation also initiates a complex cascade of chromatin factor recruitment that ultimately culminates in transcriptional elongation. Specifically, by creating a docking site for 14-3-3-ε and 14-3-3-ζ, H3S10 phosphorylation triggers histone acetylation, followed by the recruitment of BRD4 (bromodomain-containing protein 4)-pTEFb (positive transcription elongation factor b) to modify the carboxyterminal domain (CTD) of RNA polymerase II (Pol II) and promote transcriptional elongation 31 . Similarly to H3S10 phosphorylation, H3Y41 phosphorylation by Janus kinase 2 (JAK2) perturbs HP1α binding. As constitutive activation of JAK2 commonly occurs in haematological malignancies, increased H3Y41 phosphorylation in this cancer type has been proposed to contribute to genomic instability and aberrant gene activation through loss of HP1α function at chromatin 32 . Although many sites of histone phosphorylation have been identified, how these marks influence the deposition or activity of each other in cis or trans is much less characterized. For example, residues proximal to Ser10 on the H3 tail are also phosphorylated in response to pathway activation, including but not limited to, the phosphorylation of Thr6 and Thr11 by protein kinase Cα (PKCα) and checkpoint kinase 1 (CHK1), respectively. High-resolution nuclear magnetic resonance (NMR) spectroscopy has been used to evaluate the hierarchy of phosphorylation events at these three proximal sites on a single H3 molecule. It was shown that PKCα and CHK1 can also phosphorylate Ser10 and that this initial event would prevent subsequent modification of Thr6 or Thr11 on the same molecule. By contrast, phosphorylation of Thr6 or Thr11 has no effect on Ser10 phosphorylation by CHK1, PKCα or Aurora B. Thus, Ser10 phosphorylation is positioned atop the hierarchical ladder, preventing nearby phosphorylation events in cis 33 . Phosphorylation can also actively preclude demethylating enzymes from removing methylation marks in cis 34 or block the recruitment of Lys methyltransferases and deacetylases to a particular residue to allow acetylation at that site 35 . For example, phosphorylation of H3T11 by the oncogenic M2 isoform of pyruvate kinase (PKM2) precludes histone deacetylase 3 (HDAC3) retention on chromatin, resulting in histone H3 acetylation and transcription of the potent oncogenes MYC and CCND1 (cyclin D1) 36 . In summary, signal-induced phosphorylation of histones mediates the rapid conversion of one chromatin read-out to another. To completely understand this process, however, more research is needed to define the relative permanence of the various signalinduced histone modifications and the crosstalk between these marks.
Feedback and signalling out from chromatin. A series of positive and negative feedback loops must exist to achieve homeostasis. This is true both at the organismal level (for example, during endocrine signalling) and at the cellular level. During growth factor-stimulated signal transduction, for example, receptor activation usually involves phosphorylation of the receptor intracellular domain and factors in the downstream kinase cascade. Often, this same cascade activates a phosphatase that then removes the activating phosphorylation marks, thereby shutting down the very signal that activated it. In this way, receptor activation persists for a defined amount of time, to ensure a controlled response by the cell. Disruption of these negative feedback loops can lead to cancer 37 . Feedback also occurs in transcriptional programmes; early, mid and late rounds of gene transcription cross-regulate each other. Chromatin regulators affect this process; one round of gene activation can lead to the expression of enzymes that then alter the chromatin landscape to promote or reduce the expression of other genes in the same pathway. For example, the transcription factor forkhead box O1 (FOXO1) targets the SIRT1 (sirtuin 1) gene to increase SIRT1 protein expression. SIRT1 then binds to and deacetylates FOXO1 to further activate this transcription factor, thus forming a positive feedback loop 38 .
Aside from the traditional role of chromatin regulators in transcription, feedback control can also occur via signalling emanating from chromatin (that is, insideout signalling). Taking the DNA damage response as an example, the specific event of double-strand break induction on chromatin triggers a response that repairs and monitors the damage while also controlling the cell cycle. Thus, the cascade is moving away from, instead of towards, the chromatin and is independent of transcription. This idea of direct (indirect being through transcriptional regulation) inside-out signalling from chromatin in contexts other than DNA damage is relatively new. It is established that histone modifications can influence other histone modifications, but whether histone modifications can signal to non-histone proteins is less clear. Such crosstalk with non-histone proteins has been shown for ubiquitylation of histone H2B at Lys123, which is required for methylation of the non-histone protein DAM1 at kinetochores 39 . Additional studies to explore crosstalk -between PTMs on histones and nonhistone proteins, between histone proteins and DNA methylation and between DNA methylation and nonhistone proteins -will be important to fully understand the complexity of signalling to and away from chromatin, and how this process ensures cellular homeostasis.
Direct regulation of chromatin modifiers
The same mechanisms that regulate transcription factors can also regulate the epigenetic machinery, although key questions remain about how this occurs. When an external signal induces a major or minor overhaul of the transcriptional programme, how are chromatin factors regulated to act at the right time and place? Making a logical extension from the principles of transcription factor control, one can envision multiple ways to induce changes in the chromatin landscape in response to extracellular cues (FIG. 2) . However, so far there is only direct experimental evidence for a few of these possibilities.
Metabolic control of chromatin factors.
Metabolic pathways can communicate with chromatin, providing information about nutrient availability 40 (FIG. 2a) . Indeed, nutrient availability is one major informational resource of our bodies that is used to interpret current environmental conditions. It is therefore imperative that mechanisms are in place that relay this information to chromatin to impart changes in gene transcription, thus allowing organisms to adapt and survive. For example, in hypoxic conditions, HIF1α and HIF1β bind to and recruit the histone acetyltransferase p300 (and its homologue CREB-binding protein (CBP)) to chromatin, resulting in increased local nucleosomal acetylation and transcriptional activation of hypoxia-responsive genes. Oxygen levels may also directly regulate the expression and catalytic activity of JMJC (Jumonji C) domain-containing Lys demethylases 41, 42 , as these enzymes are 2-oxoglutarate-dependent di oxygenases. Indeed, metabolites are used as cofactors by many chromatin-modifying enzymes, so it is possible that the local availability of these cofactors could affect enzymatic performance. Alternatively, metabolite pools that accumulate around chromatin territories can also be natural enzymatic inhibitors. Supporting this notion, the oncometabolite 2-hydroxyglutarate precludes cellular differentiation by inhibiting Lys demethylases 43, 44 . Furthermore, during times of starvation or limited carbohydrate availability, levels of the ketone body β-hydroxybutyrate increase and inhibit HDAC activity 45 . Glucose-sensitive O-GlcNAcylation of histones, histone-modifying enzymes and multiple transcription factors, including Pol II, has been reported 46, 47 . O-linked β-d-N-acetylglucosamine (O-GlcNAc) transferase (OGT) uses uridine diphosphate N-acetylglucosamine (UDP-GlcNAc) as a donor towards the addition of GlcNAc at Ser or Thr residues, often in lieu of phosphorylation at that site. Multiple nutrient sensing pathways regulate the levels of UDP-GlcNAc and could therefore have an impact on the extent of O-GlcNAcylation occurring on chromatin. The consequence and longevity of chromatin O-GlcNAcylation are still largely unknown and warrant further research to better understand how nutrient availability may affect gene expression acutely and possibly epigenetically (for a more detailed discussion of crosstalk between metabolic pathways and chromati n, see .
Kinase cascade regulation of chromatin-modifying enzymes. Aside from the metabolic pathways mentioned above, activated kinase cascades can actively signal to chromatin-modifying factors to alter the chromatin landscape (FIG. 2b) . Phosphorylation of these For example, oxygen is required for the activity of the Jumonji C (JMJC) family of Lys demethylases. The extent to which a hypoxic environment inhibits the various JMJC demethylases is not known. Hypoxia can lead to histone acetylation around hypoxia-inducible factor 1α (HIF1α) and HIF1β target genes via the recruitment of p300. Dietary Met is a precursor of the methyl donor S-adenosylmethionine (SAM), which is required for DNA, Lys or Arg methylation (Me) events, and glucose metabolism through the tricarboxylic acid (TCA) cycle produces α-ketoglutarate, which is also required for JMJC demethylase activity. Glucose metabolism through the hexosamine biosynthetic pathway produces uridine diphosphate N-acetylglucosamine (UDP-GlcNAc), which is used by O-linked β-d-N-acetylglucosamine transferase (OGT) to trigger O-GlcNAcylation of enzymes that regulate chromatin modification, histones and transcription factors (TFs). Acetyl-CoA that is produced from citrate exiting the TCA cycle also provides the donor group for protein acetylation (Ac). b | A simplified and generic kinase cascade that collides with chromatin modifying factors in the nucleus. Signal-induced post-translational modifications (PTMs) of enzymes (such as phosphorylation) may alter enzyme activity in modifying histone or DNA residues. Enzyme modification of ATP-dependent chromatin remodellers can also alter their effects on nucleosome repositioning, changing the modification landscape or DNA accessibility around particular gene promoters or enhancers. Controlling enhancer activity or responsiveness to signals through nearby histone tail modifications and transcription factor binding site accessibility may be a crucial process in cell fate decisions, as enhancer utilization drives tissue-specific gene expression 115 . Phosphorylation-dephosphorylation events on histone chaperones can alter their ability to deposit histone variants into functionally important genomic areas, such as around the transcriptional start sites of genes. Reader proteins may also be direct targets of signalling cascades; changing the ability of these proteins to recognize the PTMs on chromatin and therefore the recruitment of additional regulators can completely switch the biological consequence of a chromatin modification. Another mechanism at work is complex nucleation initiated by a signalling event. In this case, one or a few proteins are maintained on or nearby their target genes, poised but not active, and acting as a 'placeholder' for rapid induction. Upon a signalling event, the placeholders nucleate the remaining protein complex and a function is executed. Due to the rapid nature of this response, complex nucleation may be most prevalent during primary response gene (PRG) induction.
Bivalent domains
Chromatin regions that harbour 'active' and 'repressive' histone modifications. Bivalent domains are thought to mark genes that are expressed at low levels only, but that are poised for activation upon a differentiation cue or other signalling events.
Primary response genes factors is the best-described mechanism of communication and will thus be the focus here. However, it is reasonable to assume that signalling cascades also relay information to chromatin-modifying factors through other means, such as other types of PTM and sequestration. We discuss illustrative examples of mechanisms of signalling to chromatin through chromatin-modifyin g factors, focusing on chromatin methylation, chromatin remodelling and the deposition of histone variants. A more comprehensive list of signal-induced PTMs of chromatin-modifying enzymes is shown in (FIG. 3a) . Other chromatin-modifying enzymes, including the demethyl ase KDM4B and the methyltransferases SET1A and DNMT3B, contain phosphorylation sites (identified in large proteomic studies) within AKT consensus motifs, and are thus likely to be additional targets (FIG. 3b) . In this section, we review the reported consequences of AKT phosphorylation on two c hromatin-modifying enzymes, DNMT1 and EZH2.
During replication, the pattern or 'signature' of methylated DNA is preserved by DNMT1. These patches of methylated DNA are positioned to maintain silencing of developmental genes, repetitive elements and endogenous retroviral sequences 55 . It is essential that DNMT1 activity is regulated, as its misregulation could lead to loss of this DNA methylation pattern and gene expression changes after multiple rounds of cell division. This could in turn promote tumori genesis if an oncogene were to be reactivated or a tumour suppressor gene were to be silenced. DNMT1 can be regulated via AKT-mediated phosphorylation, which is stimulated by growth factors, cytokines, hormones and pro-survival signals. AKT-induced phosphorylation of DNMT1 at Ser143 blocks monomethylation of the adjacent Lys142 residue by the methyltransferase SET7/9 (also known as SETD7). As methylation at Lys142 promotes DNMT1 degradation by the proteasome, AKT phosphorylation increases the stability of DNMT1 (REF. 56 ). Phosphorylation of the same Ser143 residue of DNMT1 also prevents association with the E3 ubiquitin ligase UHRF1 (REF. 57 ), a crucial partner for the maintenance of DNA methylation during replication [58] [59] [60] . Together, these findings suggest that Ser143 phosphorylation increases the protein levels of DNMT1 but prevents its association with the replication fork. It has been proposed that this mechanism could explain the global DNA hypomethylation observed in cancer cells. Indeed, the PI3K-AKT pathway is often overactive in cancer cells 61 , but it remains to be determined whether DNMT1 activity is promiscuous in such tumours and whether it alters the DNA methylation signature globally or at select gene promoters.
EZH2 is the catalytic subunit of the polycomb repressive complex 2 (PRC2) 52 ). In addition to gene promoters, distal regulatory enhancer elements are marked by defined H3K27 modification states; poised but silent enhancers display the H3K27me3 mark 63 , whereas activated enhancers display H3K27 acetylation 64 . The histone acetyltransferase p300 (or CBP) acetylates H3K27 and, concordantly, p300 is found bound to active enhancers 65 . Furthermore, the co-activator activity of p300 is increased by AKT phosphorylation 54 . It will therefore be interesting to determine whether PI3K-AKT signalling could activate gene enhancer elements by inhibiting EZH2 and activating p300 to switch H3K27 from a trimethylated state to an acetylated state (FIG. 3c) . We speculate that AKT may be a major regulator of enhancer activity. p38 phosphorylation of a chromatin remodelling subunit. The SWI/SNF family of chromatin remodelling enzymes can promote 'sliding' of nucleosomes to reveal or hide DNA sequences and thereby control the access of transcription factors to particular genes 66 . For example, the transcription factor MyoD (myoblast determination), a master regulator of muscle differentiation, resides poised at target genes in myoblasts so that it can trigger the differentiation programme in response to the appropriate cue. As the chromatin is condensed around muscle genes in myoblasts, MyoD retention depends on binding of the SWI/SNF subunit BAF60C. Upon differen tiation, BAF60C is phosphorylated by p38α and p38β, creating a nucleating site for the remaining SWI/SNF components. This allows chromatin remodelling and exposes MyoD target sequences, thus enabling muscle-specific gene expression and muscle differentiation 67 . Similar modes of regulation have been demonstrated in other contexts and, in each case, one subunit of a large protein machine sits at target regions, poised and possibly acting as a 'placeholder' . Upon stimulation, the remaining complex nucleated by this factor is formed for rapid and directed activation of primary response genes (PRGs) 68 . Inhibition of PRMT5 by JAK2 phosphorylation. Protein Arg N-methyltransferase 5 (PRMT5) symmetrically dimethylates Arg residues in non-histone and histone substrates, resulting in a broad range of biological outcomes 69 . The transcriptional influence of PRMT5-mediated histone methylation can be positive or negative, depending on the histone site that is modified, the cell type and the particular gene. In one instance, PRMT5 methylation of Arg3 in H4 results in gene repression through the recruitment of the DNA methyltransferase DNMT3B 70 . PRMT5 has an unexpected role in myeloproliferative neoplasms, in which the oncogenic forms of JAK2 phosphorylate PRMT5, thereby inhibiting PRMT5 activity and preventing histone methylation. This loss of PRMT5 activity promotes haematopoietic progenitor cell proliferation and expansion. Thus, one oncogenic function of mutant JAK proteins is to inhibit PRMT5 activity to alter the gene transcription profile and encourage progenitor cell expansion in myelo proliferative neoplasms 71 . This study elegantly demon strated direct regulation of a h istone-modifying enzyme by an activated kinase cascade. Unlike histone This results in activation of PI3K at the intracellular domain of the receptor, followed by PI3K-induced production of phosphatidylinositol-3,4,5-triphosphates (PtdIns(3,4,5)P 3 ). PtdIns(3,4,5)P 3 production creates docking sites for phosphoinositide-dependen t kinase 1 (PDK1) and AKT, thus allowing phosphorylation and activation of AKT by PDK1. Many cellular pathways are regulated by AKT signalling. Depicted are epigenetic enzymes that are targeted by AKT, including the histone methyltransferase EZH2, the histone ubiquitylating enzyme BMI1, the histone acetyltransferase p300 and the DNA methyltransferase DNMT1. AKT-mediated phosphorylation of these enzymes may have several effects, for example altering catalytic activity in the case of EZH2 and p300, altering protein stability or retention at the replication fork in the case of DNMT1, or increasing the ubiquitin ligase activity of BMI1 towards H2A after DNA damage. b | Other chromati n-modifying enzymes contain AKT target motifs (that is; R-X-R-X-X-S/T; Arg residues are boxed in blue and Ser/Thr residues in orange). Listed are potential phosphorylation sites for KDM4B (a demethylase for histone H3 Lys 9 dimethylation (H3K9me2) or H3K36me3), SET1A (a H3K4 methyltransferase) and DNMT3B (a de novo DNA methyltransferase). Although more enzymes contain putative AKT sites, each of these highlighted sites has been identified multiple times as phosphorylated peptides in large proteomic studies aimed at identifying new AKT targets (PhosphoSitePlus). c | The modification state of H3K27 is one major chromatin feature that is highly predictive of enhancer activity. Methylation at this residue by EZH2 marks an inactive, and possibly poised, enhancer, whereas acetylation of H3K27 by p300 marks an active enhancer that is engaged in transcription with promoter regions. AKT phosphorylation of EZH2 limits its ability to methylate H3K27, whereas AKT phosphorylation of p300 promotes transactivation.
acetylation and methylation at Lys residues, it is still unclear how histone Arg methyl ation is dynamically regu lated, that is, whether Arg methylation is turned over by demethylating enzymes and whether such turnover would be common or only occur selectively at particular times during development. Indeed, if histone methylation at Arg residues is a long-lived epi genetic event similar to that of DNA methylation, regulating the PRMT family of enzymes by signal transduction would be a powerful way to leave a lasting impression on the gene expression signature.
PKCζ phosphorylation of NF-kB controls histone methylation. The nuclear factor-kB (NF-kB) signalling pathway is central to cellular immune responses and is activated by pro-inflammatory cytokines. Consequently, this pathway must be regulated to ensure an effective but controlled response. Indeed, its over-reactivity has been implicated in autoimmune diseases. Moreover, in cancer, the activation of the NF-kB pathway by the tumour microenvironment results in the induction of pro-survival genes and an enhanced local inflammatory response, creating a dangerous positive feedback loop. Therefore, the mechanisms that properly regulate NF-kB function are clinically important. One intricate NF-kB regulatory mechanism involves crosstalk between histones, histone-modifying enzymes and Lys methylation. Before pathway activation, a fraction of RelA (a component of the NF-kB transcriptional unit) is located in the nucleus and is monomethylated by SETD6. This methylation event creates a docking site for the histone methyltransferase GLP, and GLP subsequently methylates Lys9 of H3 to repress NF-kB target gene expression. Upon pathway stimulation by tumour necrosis factor (TNF), RelA is phosphorylated by PKCζ on a residue that lies adjacent to the methylation site. This event abrogates GLP binding, allowing demethylation of H3K9 and NF-kB target gene activation 72 . Thus, pathway stimulation by an inflammatory response can change the methylation state of chromatin, and therefore transcriptional responsiveness, by regulating histone methyltransferase recruitment to chromatin through crosstalk between PTMs on a classi c transcription factor.
Calcium signalling control of histone variant deposition.
How are the experiences of an organism converted and transformed into changes in neuronal morphology, neuronal responsiveness and neural wiring? This question has been intensely investigated for over a century. Chromatin-modifying enzymes are emerging as crucial factors during brain formation in utero and perinatally, as many mutations causing neurodevelopmental disorders reside in genes encoding histone-modifying enzymes
. In post-mitotic neurons, long-term memory formation requires transcription and new protein synthesis after neuron stimulation. One emerging theory is that the chromatin of neurons is slightly restructured after each stimulation event (or organismal experience), providing a mechanism for tuning that neuron to a precise function within the brain circuitry and retaining heightened sensitivity to a particular stimulus. Indeed, histone acetylation is required in the brain for traininginduced memory formation 73 (for a review of chromatin modification in the central nervous system and during memory formation, see REF. 74 ). Upon neuronal activation, a rapid wave of gene expression is induced 75 . This activation of immediate-early genes (IEG) and subsequent protein translation are required for many types
Box 1 | Depositing and maintaining the proper histone methylation landscape during neurodevelopment
Many different genetic mutations have been linked to neurodevelopmental disorders, such as autism and intellectual disability. Interestingly, a large number of causative genetic mutations have been found in genes encoding enzymes that catalyse the addition or removal of the trimethylation mark of Lys4 on H3 (H3K4me3) and H3K9me2 (REF. [108] [109] [110] [111] [112] [113] [114] (see  the table) . Histones at the promoter regions of transcriptionally active genes are marked with H3K4me3. Conversely, as developmental genes become silenced during differentiation, they are marked with H3K9me2. These histone markings do not just correlate with the transcriptional status but also functionally oppose each other by providing docking platforms for effector proteins and thereby contribute to gene expression control. The disease associated mutations highlighted here strongly suggest that the balance between two functionally opposing histone methylation marks, and perhaps uncharted methylation events on non-histone proteins, is important during neurodevelopment. One possibility is that epigenetic events such as this are integral in the precise repression kinetics of developmental and cell cycle genes as neurons exit the cell cycle and pattern the brain. Furthermore, in mature neurons, direct signalling to the enzymes that control these marks after synaptic transmission and membrane depolarization may be a crucial step in the establishment of individualized chromatin landscapes, influenced by the particular fate and experience of each neuron. of memory formation in vivo 76 . Chromatin regulation during this process has been partially characterized and includes calcium signalling-induced phosphorylation of key transcription factors such as cAMP-responsive element-binding protein (CREB) as well as activation of their associated cofactors. Histone variant deposition provides another level of regulation in neuronal signalling. Histone variant H3.3 is deposited in a replication-independent manner, as opposed to H3.1 (REF. 77 ), and therefore is predicted to be the primary histone H3 variant that is newly deposited in post-mitotic neurons. After neuro nal stimulation, calcium-dependent signalling leads to the dephosphorylation of DAXX, which is an H3.3 chaperone. This increases DAXX binding to H3.3 and DAXX-dependent deposition of H3.3 after transcriptional initiation at select IEG regulatory regions, ultimately allowing full activation of these genes 78 . Although all IEGs tested have increased deposition of H3.3 after activation, some events are independent of DAXX, implying that other H3.3 chaperones also regulate this pathway. Another outstanding question is how DAXX, and presumably other H3.3 chaperones, are targeted to IEGs after neuronal stimulation. Importantly, the de position of H3.3 is crucial for cellular storage of active gene regions in the absence of transcription 79 . This may prove essential for neurological memory, as long periods of time may pass between retrieval of particular memories. It will be important to determine how neuronal signalling events coordinate histone variant deposition, and what the contribution and significance of variant deposition are for neuronal function, learning and memory.
Gene

Regulation through histone mimics
Signalling to chromatin requires that environmental information is transmitted not only to nucleosomes but also to chromatin-associated factors, as discussed above. It is now becoming clear that some chromatinassociated factors are modified and 'read' by the same protein complexes that modulate nucleosomes. Of particular relevance, simultaneous binding of reader Residues that are common with H3 or H4 are depicted in pink. These highly conserved histone tail-like sequences illustrate that it is likely that multiple non-histone proteins modulating chromatin are subject to modification by the same enzymes that modify the histone tails. b | Histone-mimic sequences have been well-characterized within the methyltransferase G9A and the tumour suppressor p53. Examples of respective homologous protein motifs are shown and the common residues highlighted in yellow. c | The reader protein MPP8 (M phase phosphoprotein 8) can recognize methylated histone-mimic motifs within the histone methyltransferase GLP and the de novo DNA methyltransferase DNMT3A, linking dimethylation of Lys9 on histone H3 (H3K9me2) with de novo DNA methylation by DNMT3A. One possibility is that a single signalling event might trigger simultaneous automethylation of GLP and methylation of DNMT3A to coordinate histone and DNA methylation events in close vicinity. ATF7IP, activating transcription factor 7-interacting protein 1; BRWD3, bromodomain and WD repeat-containing protein 3; CREBZF, CREB/ATF bZIP transcription factor; DHX34, DEAH box protein 34; FMR2, fragile X mental retardation 2; FOXC2, forkhead box C2; MLL, mixed-lineage leukaemia; TAF11, transcription initiation factor TFIID subunit 11; ZNF, zinc-finger.
proteins to similarly modified motifs in different proteins provides an opportunity for signalling-mediated control. Combinatorial domain binding to chromatin is frequent and may be more common in vivo than individual domain binding to a single chromatin modification. Indeed, many chromatin-associated proteins have multiple reader domains, including chromatinmodifying enzymes themselves (FIG. 1) . In addition to multiple chromatin-binding domains, many chromatin regulators are found as homodimers in their associated protein complexes 80, 81 . This common feature suggests that protein complexes can recognize multiple histone molecules and/or non-histone proteins simultaneously, especially if the same motif within multiple proteins is modified in a similar way. This idea of modification cassettes was posited in 2003 and is now gaining support 82 . For example, the function of a protein complex may be partly inhibited until the appropriate modifications have been added to multiple proteins of this complex or histones, allowing cellular events to be coupled with changes in chromatin. The basic local alignment search tool (BLAST) predicts that a number of nuclear proteins possibly have histone-mimic motifs (FIG. 4a) . It will be interesting to determine whether some of these proteins are co-modified with histones to synchronize cellular events. Alternatively, histone-mimic modification may also create 'dummy' motifs that compete with reading of modifications on the histone tails. Indeed, compounds that are structurally similar to modified histone tail motifs can selectively block reader domains from binding their targets on chromatin 83 , and an influenza virus protein (NS1) that harbours an H3-like motif can 'siphon' the human transcription machinery away from chromatin and suppress the antiviral response 84 .
G9A and GLP contain H3-like motifs. The methyltransferase G9A (also known as EHMT2) automethylates Lys165 within the same Ala-Arg-Lys-Ser/Thr motif that surrounds its H3 target residue, Lys9 (REFS 85, 86) (FIG. 4b) . Consistent with this, automethylation creates a docking site for HP1γ, and this interaction has similar binding kinetics to that between HP1γ and H3K9me3. In addition to Lys165 methylation, Thr166 is phosphorylated in vitro, suggesting that this sequence within G9A is a hotspot for modifications. The function of G9A automethylation is unclear; mutation of this residue to Ala does not alter target gene transcription. Perhaps the G9A H3-like motif supports complex assembly. Indeed, Lys205 of GLP, a mammalian homologue and heterodimerization partner of G9A 87 , is automethylated to create a docking site for another chromodomain-containing protein, MPP8 (M phase phosphoprotein 8). A MPP8 dimer then simultaneously binds methylated GLP and methylated DNMT3A (a de novo DNA methyltransferase) to tether two transcriptionally repressive events, namely H3K9 methylation and DNA methylation, to the same complex for tight co-regulation 81 . So, loss of the methyl-motif within G9A or GLP might result in gene expression changes that are linked to de novo DNA methylation (FIG. 4c) .
p53 contains an H4-like motif. p53 is the most extensively studied tumour suppressor, and with good reason. This transcription factor is mutated or lost in up to 80% of cancers. p53 is crucial for diverse cell biological processes, including cell cycle control, DNA repair, metabolism, senescence, apoptosis, autophagy and necrosis. For p53 to function effectively at the right time and place, it must be tightly regulated. One mechanism by which p53 is controlled is through post-translational modification of its CTD. Although the precise function of the C terminus of p53 has been debated, it is clearly required for p53-mediated transcription of naked DNA and chromatin templates 88 . Interestingly, a stretch within the p53 CTD looks similar to a motif within the tail of H4 (FIG. 4b) . Indeed, this histone-mimic sequence in p53, its multiple modifications by histone-modifying enzymes and subsequent association of reader domains at this site is one of the best characterized models of a histone mimic [89] [90] [91] (for a review, see REF. 92 ). Interestingly, the crystal structure of PHF20 (PHD finger protein 20), a reader molecule that associates with methylated p53, has been solved. Supporting the idea that a protein dimer binds two histone or histone-mimic motifs simultaneously, PHF20 forms a homodimer that has a greatly enhanced capacity to bind p53 modified on two different Lys residues, as opposed to a single modification 93 . PHF20 functions as a co-activator of the histone acetyltransferase MOF (also known as KAT8) 94 , and together they enhance the transcription factor function of p53 (REF. 95 ). This suggests that the double modification at the p53 CTD which promotes PHF20 binding could greatly enhance p53 activity. One possible explanation for disparate reports of the function and importance of the p53 CTD may be because it is indeed an extensively modified region. Similarly to modifications of histone tails, each modification pattern on p53 might have a different downstream consequence.
The Pol II C-terminal domain as a PTM hub. Although it is not an apparent histone mimic by sequence, the C-terminal regulatory domain of Pol II is a crucial regulatory module for controlling transcription initiation and elongation that, similarly to the histone tails, undergoes extensive post-translational modification 96 . This may have possible implications for how transcription is regulated through coordinated control of both chromatin and Pol II. The established model is that the Pol II CTD is phosphorylated on different Ser residues within a 52 heptad repeat sequence. Phosphorylation at Ser5 is observed on a polymerase that has progressed past the promoter region but remains paused, whereas phosphorylation at Ser2 and Ser5 marks the elongating form of Pol II 97 . The Pol II CTD is phosphorylated at other Thr residues 98 , and is also Tyr-phosphorylated and O-GlcNAcylated, and the downstream consequences of these events are now being elucidated. Tyr1 phosphorylation, for example, blocks the tethering of termination factors to Pol II while it is in gene bodies and so ensures that termination occurs only after transcription is complete 99 . O-GlcNAcylation of promoter-bound Pol II may temporarily oppose the phosphorylation events required for elongation 100 , an event that could be responsive to metabolic glucose levels.
There are some exceptional residues within the CTD repeat that differ from its canonical Tyr-Ser-ProThr-Ser-Pro-Ser sequence. Interestingly, this variation usually involves a substitution of Ser7 with a Lys or Arg residue, providing the option for Lys ubiquitylation and Lys or Arg methylation. Indeed, Arg in the CTD is methylated by CARM1 (co-activator-associated Arg methyltransferase 1) and this recruits the reader molecule TDRD3 (Tudor domain-containing protein 3) 101 . TDRD3 also binds methylated Arg residues on histone tails (H3R17me2 and H4R3me2) and, in so doing, acts as a strong transcriptional co-activator 102 . It remains to be determined whether more than one TDRD3 protein exists within a single complex that could bridge methylated histone to methylated Pol II. This example may typify a common mechanism, whereby enzymes co-modify chromatin and Pol II in response to a cellular signal to coordinate a transcriptional event. Supporting this theory, it has been shown that in response to serum stimulation, the CTD of Pol II is phosphorylated by pTEFb, and this requires that H3S10 first be phosphorylated by PIM1 kinase 31 . Together, these findings support the notion that a dense platform of PTMs in the CTD region of Pol II precisely controls polymerase function.
Conclusions and perspectives
There have been many descriptions of how the chromatin landscape is 'stamped, erased and transmitted' , but when this occurs physiologically is unclear. One emerging mechanism is direct communication between signalling molecules and the chromatinmodifying machinery. Activated kinases, for example, can directly modify histone tail residues to switch the functional read-out and thereby influence transcription. Activated cascades can also modify methylating enzymes, remodellers and histone chaperones to change their activity on chromatin. However, the evidence to support this has been largely obtained using cell-based model systems. In vivo demonstrations of signalinduced chromatin alterations is still lacking and is key for tying our current mechanistic knowledge together with that of organismal physiology. In the future, it may prove fruitful to further scrutinize well-characterized in vivo models of particular signalling pathways (such as the insulin pathway) for temporal changes in chromatin landscape, structure, occupancy and activity in response to a stimulus or pharmacological inhibition.
In particular, a further understanding of how different metabolic states influence the activities and modifications on chromatin in vivo would be especially timely considering the increasing rates of metabolic disease and type II diabetes in the western world.
Signalling events occurring throughout the lifetime of a cell can be integrated and stored on chromatin to influence the amplitude of gene expression. A key task for the future is to define which chromatin-altering signalling events are transient and which are truly epigenetic (that is, allowing a heritable change in gene expression). The developmental stage at which a signal is initiated most certainly influences the extent of the epigenetic engagement it triggers. For example, during different stages, the expression level or cellular localization of epigenetic regulators may change their responsiveness to signalling pathways. Increased communication between the environment and our epigenomes is observed clinically as developmental windows of plasticity or susceptibility, occurring during embryogenesis, childhood and adolescence, when environmental factors or situations are more likely to have an impact on the health or development of the person. The effects of environmental exposure during these critical periods are also more likely to persist into adulthood. If the molecular mechanisms that define windows of epigenetic engagement can be bette r characterized, this knowledge may in turn increase the possibility of artificially recreating such windows for more effective treatment of developmental disorders.
Signal transduction resulting in epigenetic changes fixes a cellular experience into the epigenome. As is true for many pathological situations, the exploitation of these same epigenetic mechanisms can lead to disease later in life. For example, exposure to dietary restrictions early in life results in increased susceptibility for various adult diseases [103] [104] [105] , and traumatic events result in post-traumatic stress disorder (PTSD) 106, 107 . At the cellular level, cancer cells responding to growth factors capitalize on the pathways that feed into epigenetic regulation to convert themselves into a more stem cell-like state with greater proliferation potential and also adjust their programmed metabolic needs to tolerate limited oxygen and nutrient supply. Therefore, the elucidation of how epi genetic mechanisms respond to and feed back to the environment is crucial for fully understanding development, trans-generational effects of short-lived environment al occurrences and disease pathology.
